Search results
Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up
Zacks via Yahoo Finance· 4 months agoSolid Biosciences (SLDB) stock rises after the FDA grants the orphan drug designation to the...
Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug
Zacks via Yahoo Finance· 1 month agoSolid Biosciences' (SLDB) novel gene-therapy candidate, SGT-003, gets FDA's Rare Pediatric Disease...
Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND
Zacks via Yahoo Finance· 6 months agoSolid Biosciences (SLDB) gains 28% as the FDA clears SGT-003, a gene therapy candidate, for clinical...
Solid Biosciences Inc.'s (NASDAQ:SLDB) 14% loss last week hit both individual investors who own 51%...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Significant control over Solid Biosciences by private equity firms implies that the...
Earnings Preview: Solid Biosciences Inc. (SLDB) Q3 Earnings Expected to Decline
Zacks via Yahoo Finance· 2 years agoSolid Biosciences Inc. (SLDB) doesn't possess the right combination of the two key ingredients for a...
Earnings Update: Solid Biosciences Inc. (NASDAQ:SLDB) Just Reported Its Second-Quarter Results And...
Simply Wall St. via Yahoo Finance· 2 years agoInvestors in Solid Biosciences Inc. (NASDAQ:SLDB) had a good week, as its shares rose 5.5% to close...
While institutions invested in Solid Biosciences Inc. (NASDAQ:SLDB) benefited from last week's 68%...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights The considerable ownership by private equity firms in Solid Biosciences indicates that...
Solid Biosciences Inc. (SLDB) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoSolid Biosciences Inc. (SLDB) delivered earnings and revenue surprises of -4.76% and 77.27%,...
Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why
Zacks via Yahoo Finance· 4 months agoThe FDA's recent clearance of Solid Biosciences' (SLDB) investigational new drug application on...
Solid Biosciences Full Year 2022 Earnings: EPS Misses Expectations
Simply Wall St. via Yahoo Finance· 1 year agoSolid Biosciences (NASDAQ:SLDB) Full Year 2022 Results Key Financial Results Net loss: US$86.0m...